Author

Emilien J. Loeuillard

Mayo ClinicORCID 0000-0002-3650-8100Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Binbin LiiD· 1 shared Fred Rakhshan Rohakhtar· 1 shared Haidong DongiD· 1 shared Hannah E. StumpfiD· 1 shared Jennifer L. TomlinsoniD· 1 shared Jessica Willhite· 1 shared Jingchun YangiD· 1 shared Juan Wang· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Binbin LiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCellular and Molecular Gastroenterology and HepatologyPeer-reviewedJan 1, 2024

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma

Emilien J. Loeuillard, Binbin Li, Hannah E. Stumpf…·Sumera Irie Ilyas

This study shows that TRAIL+ cancer cells use noncanonical TRAIL signaling in MDSCs to promote their abundance and tumor progression in cholangiocarcinoma.

14 citations

mousescRNA-seq

𝕏 PostBluesky